Dangerous Drugs recently published news that the drug Samsca (tolvaptan) has been associated with “irreversible and potentially fatal liver injury.”
The news was first broken by the FDA, which discovered the association between Samsca use and liver damage as part of a “double-blind, 3-year, placebo-controlled study” of about 1,400 patients with a type of kidney disease.
As a result of this, many Samsca lawyers are now reviewing potential Samsca lawsuits. Although it is too early to tell which lawsuits will succeed, attorney Justinian Lane is willing to speak to anyone who suffered liver damage while taking the drug Samsca.
For more information, see Justinian Lane’s post at Dangerous Drugs here.